Current generation time-of-flight 18F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands

10Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: Modern PET/CT scanners have significantly improved detectors and fast time-of-flight (TOF) performance and this may improve clinical performance. The aim of this study was to analyze the impact of a current generation TOF PET/CT scanner on standardized uptake values (SUV), lesion-background contrast and characterization of the adrenal glands in patients with suspected lung cancer, in comparison with literature data and commonly used SUV cut-off levels. Methods: We included 149 adrenal glands from 88 patients with suspected lung cancer, who underwent 18F-FDG PET/CT. We measured the SUVmax in the adrenal gland and compared this with liver SUVmean to calculate the adrenal-to-liver ratio (AL ratio). Results were compared with literature derived with older scanners, with SUVmax values of 1.0 and 1.8 for normal glands [1, 2]. Final diagnosis was based on histological proof or follow-up imaging. We proposed cut-off values for optimal separation of benign from malignant glands. Results: In 127 benign and 22 malignant adrenal glands, SUVmax values were 2.3 ± 0.7 (mean ± SD) and 7.8 ± 3.2 respectively (p < 0.01). Corresponding AL ratios were 1.0 ± 0.3 and 3.5 ± 1.4 respectively (p < 0.01). With a SUVmax cut-off value of 3.7, 96 % sensitivity and 96 % specificity was reached. An AL ratio cut-off value of 1.8 resulted in 91 % sensitivity and 97 % specificity. The ability of both SUVmax and AL ratio to separate benign from malignant glands was similar (AUC 0.989 vs. 0.993, p = 0.22). Conclusions: Compared with literature based on the previous generation of PET scanners, current generation TOF 18F-FDG PET/CT imaging provides higher SUVs for benign adrenal glands, while it maintains a highly accurate distinction between benign and malignant glands. Clinical implementation of current generation TOF PET/CT requires not only the use of higher cut-off levels but also visual adaptation by PET readers.

References Powered by Scopus

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

2405Citations
N/AReaders
Get full text

Evaluation of adrenal masses in patients with bronchogenic carcinoma using <sup>18</sup>F-fluorodeoxy-glucose positron emission tomography

316Citations
N/AReaders
Get full text

Distribution of distant metastases from newly diagnosed non-small cell lung cancer

296Citations
N/AReaders
Get full text

Cited by Powered by Scopus

EUS-B-FNA vs conventional EUS-FNA for left adrenal gland analysis in lung cancer patients

43Citations
N/AReaders
Get full text

The utility of 18 F-FDG PET/CT for the diagnosis of adrenal metastasis in lung cancer: A PRISMA-compliant meta-analysis

20Citations
N/AReaders
Get full text

PET/CT of Osteosarcoma and Ewing Sarcoma

18Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Koopman, D., van Dalen, J. A., Stigt, J. A., Slump, C. H., Knollema, S., & Jager, P. L. (2016). Current generation time-of-flight 18F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands. Annals of Nuclear Medicine, 30(2), 145–152. https://doi.org/10.1007/s12149-015-1041-z

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

47%

Researcher 6

35%

Lecturer / Post doc 2

12%

Professor / Associate Prof. 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

72%

Social Sciences 3

17%

Neuroscience 1

6%

Sports and Recreations 1

6%

Save time finding and organizing research with Mendeley

Sign up for free